Translate Bio, Inc.·4

Apr 20, 4:49 PM ET

Smith Brendan 4

4 · Translate Bio, Inc. · Filed Apr 20, 2021

Insider Transaction Report

Form 4
Period: 2021-04-19
Smith Brendan
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-04-19+201,800201,800 total
    Exercise: $19.23Exp: 2031-04-18Common Stock (201,800 underlying)
Footnotes (1)
  • [F1]This option was granted on April 19 2021. The shares underlying the option are scheduled to vest over four years, with 25% of the shares vesting on April 19, 2022 and the remainder vesting in equal monthly installments through April 19, 2025.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION